image detection systems
Recently Published Documents


TOTAL DOCUMENTS

3
(FIVE YEARS 0)

H-INDEX

2
(FIVE YEARS 0)

2014 ◽  
Vol 571-572 ◽  
pp. 747-752
Author(s):  
Yuan Long Deng ◽  
Xiao Xing Zeng ◽  
You Fu Geng ◽  
Xue Jin Li

The visual defects of the polymer polaroid have a direct and serious influence on the quality of TFT-LCD panels. A variety of image detection systems have been proposed and widely used by the manufacturers of polaroid and panels in order to detect the visual defects at the earliest possible stage in the production process. Some slight visual defects, however, are barely visible in the images acquired by a camera when under a common illumination condition. In order to deal with this problem, we present a novel machine vision system in which a stripe light source is introduced to illuminate the polaroid sample, and these special defects therefore become more visible. At the base of the aforementioned image enhancement, a straightforward and fast image processing algorithm is designed and implemented. The Morphology Template Method is investigated and the shapes, the locations and the sizes of the visual defects are extracted successfully. The experimental results demonstrate this methodology’s validity to inspect the visual defects of transparent multilayer polymer films.


2001 ◽  
Vol 14 (4) ◽  
pp. 308-331 ◽  
Author(s):  
David L. Laven ◽  
Edward M. Bednarczyk

Disorders of the brain manifest in a variety of manners ranging from feeling or thought abnormalities to total paralysis. Until recently, most imaging methods of the brain have been limited to anatomic considerations, with little information about actual function of the brain except that deduced from clinical examination and physical and cognitive assessment testing. With the advent of positron emission tomography (PET) and enhanced computer and scintigraphic image detection systems, there is keen interest in applying this imaging technique to better understand brain physiology and pathophysiology. Potential applications of PET in CNS assessment is expanding avenues for improved diagnosis and staging of disease, as well as monitoring therapeutic interventions. A general review of the radiopharmaceuticals used for neuro-PET imaging, as well as their application in situations such as cerebrovascular disease, brain activation studies, various movement disorders and dementias, depression, epilepsy, obsessive-compulsive disorder, schizophrenia, and neuropharmacology (including cerebral receptor studies) will be presented.


Sign in / Sign up

Export Citation Format

Share Document